20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Nuvectis Pharma Inc (NVCT) operates in the BIOTECHNOLOGY industry and is headquartered in Fort Lee, United States with about 16 employees. Its market capitalization is roughly $631 million. In the fiscal year ended 2025-12-31, NVCT reported $0M in revenue and ($26M) in net income.
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | ($23M) | ($19M) | ($13M) | — |
| Gross Margin % | — | — | — | — | -12808.7% | — | — |
| Operating Income (EBIT) | ($29M) | ($28M) | ($20M) | ($23M) | ($19M) | ($13M) | $0M |
| Operating Margin % | — | — | — | — | -12908.7% | — | — |
| Net Income | ($28M) | ($26M) | ($19M) | ($22M) | ($19M) | ($13M) | $0M |
| Net Margin % | — | — | — | — | -12608.7% | — | — |
| EBITDA | ($29M) | ($26M) | ($19M) | ($22M) | ($19M) | ($13M) | $0M |
| Earnings Per Share (EPS) | $-1.22 | $-1.21 | $-1.11 | $-1.43 | $-1.48 | $-1.01 | $-0.00 |
| Shares Outstanding (M) | 23M | 22M | 17M | 16M | 13M | 13M | 13M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $27M | $0M |
| Gross Profit | — | — | — | — | — | — | $13M | ($4M) |
| Gross Margin % | — | — | — | — | — | — | 50.0% | — |
| Operating Income (EBIT) | ($7M) | ($6M) | ($8M) | ($8M) | ($7M) | ($6M) | ($6M) | ($4M) |
| Operating Margin % | — | — | — | — | — | — | -24.1% | — |
| Net Income | ($7M) | ($6M) | ($7M) | ($7M) | ($6M) | ($5M) | ($6M) | ($4M) |
| Net Margin % | — | — | — | — | — | — | -23.3% | — |
| EBITDA | ($7M) | ($6M) | ($8M) | ($7M) | ($6M) | ($5M) | ($6M) | ($4M) |
| Earnings Per Share (EPS) | $-0.30 | $-0.26 | $-0.34 | $-0.33 | $-0.30 | $-0.27 | $-0.32 | $-0.24 |
| Shares Outstanding (M) | 23M | 23M | 22M | 23M | 21M | 20M | 19M | 17M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($20M) | ($16M) | ($12M) | ($16M) | ($14M) | ($10M) | $0M |
| Free Cash Flow (FCF) | ($20M) | ($16M) | ($12M) | ($16M) | ($14M) | ($10M) | $0M |
| FCF Margin % | — | — | — | — | -9100.0% | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($5M) | ($7M) | ($4M) | ($4M) | ($3M) | ($4M) | ($2M) | ($2M) |
| Free Cash Flow (FCF) | ($5M) | ($7M) | ($4M) | ($4M) | ($3M) | ($4M) | ($2M) | ($2M) |
| FCF Margin % | — | — | — | — | — | — | -9.2% | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Assets | $22M | $32M | $19M | $19M | $20M | $7M | $7M |
| Cash & Cash Equivalents | $22M | $32M | $19M | $19M | $20M | $6M | $6M |
| Total Liabilities | $13M | $13M | $9M | $7M | $6M | $18M | $0M |
| Total Debt (Short + Long-Term) | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $9M | $18M | $10M | $12M | $14M | ($11M) | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NVCT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms